The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global oncology active pharmaceutical ingredients (APIs) market is expected to exhibit strong growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Oncology APIs refer to the biologically active components present in anti-cancer drugs. The growing incidences of cancer coupled with the rising number of R&D activities pertaining to anti-cancer drugs are primarily driving the market for oncology APIs. Moreover, the increasing awareness towards the improved efficacy of various APIs on targeted cancerous cells is also propelling their demand in oncology therapeutics.
The market is further being driven by the rising investments of several biotech and pharmaceutical companies in anti-cancer drug discovery and development. The emergence of novel biomarkers with minimal effects on non-cancerous cells is also proliferating the market for oncology APIs. Besides this, the increasing consumer health concerns towards the numerous side effects of chemotherapy treatments are also augmenting the demand for biologically active drugs with lower dosages. Additionally, the market for generic oncology APIs is also exhibiting robust growth, catalysed by the rising number of patent expiries of branded blockbuster drugs. Furthermore, several technological advancements have also led to the introduction of oncology drugs with higher efficacy and minimum side effects. For instance, the increasing penetration of advanced molecular techniques, such as recombinant DNA technology is also propelling the demand for safer and target-oriented oncology drugs.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global oncology active pharmaceutical ingredients (APIs) market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on drug type, manufacturer type, type of synthesis and indication.
Breakup by Drug Type:
Breakup by Manufacturer Type:
Breakup by Type of Synthesis
Breakup by Indication:
Breakup by Region:
The report has also analysed the competitive landscape of the market along with the profiles of the key players.
|Base Year of the Analysis||2020|
|Segment Coverage||Drug Type, Manufacturer Type, Type of Synthesis, Indication, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico, Turkey, Saudi Arabia|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at